8-K/A
Current Report
Oruka Therapeutics, Inc. Filed Acc 0001193125-14-043270
Shareholder vote results
- Item 5.07 Submission of matters to a vote of security holders
From the SEC's structured data for this filing
Loading d674369d8ka.htm…